1142-OR: Counterregulatory Hormone Responses to Hypoglycemia after Total Pancreatectomy with Islet Autotransplantation (TPIAT)
Diabetes · 05.06.2026 · 75 (Supplement_1)
DOI: 10.2337/db26-1142-or ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von JENNIFER M. LADD und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction and Objective: Insulin-independent hypoglycemia has been reported after TPIAT. Our objective was to determine counterregulatory hormone responses after TPIAT.
Methods
Nineteen subjects, a mean of 9.17 (SD 3.36) years post-TPIAT (IEQ/kg 4617 (2022)), and 10 age-, sex-, and BMI-matched healthy volunteers (HV) underwent stepped hypoglycemic clamps (nadir 50 mg/dL), with serial measurements of C-peptide, pancreatic polypeptide (PP), cortisol, epinephrine (epi) and norepinephrine (NE). Mean changes from 70 mg/dL to 50 mg/dL steps were compared between groups with t-tests.
Results
TPIAT subjects had an appropriate suppression of C-peptide, but absent PP, less increase in glucagon (p=0.006), and similar cortisol, epi, and NE responses to HV (Figure 1). Responses of TPIAT subjects off opioids (N=10) were similar to TPIAT on opioids (N=9). Compared to TPIAT subjects on insulin (N=10), TPIAT off insulin (N=9) had higher glucagon response (p=0.057), but no difference in cortisol, epi or NE. TPIAT subjects with intra + extrahepatic islets (N=7) had patterns suggesting lower responses for glucagon (p=0.074), cortisol (p=0.063), epi (p=0.088), and NE (p=0.1) vs those with intrahepatic islets alone (N=12), with similar patterns when restricted to insulin-independent TPIAT subjects.
Conclusion
Other than glucagon and PP, counterregulatory responses were preserved in TPIAT. Extrahepatic islet transplantation did not improve glucagon response. Disclosure J.M. Ladd: None. A. Eaton: None. G. Beilman: None. M.R. Rickels: Consultant; Ended; Novo Nordisk. Consultant; Current; Vertex Pharmaceuticals Incorporated. Other - Invited speaker; Ended; Bayer AG. Consultant; Current; Sernova, Corp., Sanofi. Research Support; Current; Dompé, vTv Therapeutics, Hua Medicine. Research Support; Ended; Tandem Diabetes Care, Inc. M. Bellin: Other - DSMB member; Current; Vertex Pharmaceuticals Incorporated. Advisory Panel; Current; Novo Nordisk, Sana Biotechnology Inc., Sernova, Corp. Research Support; Current; Dexcom, Inc. Funding NIH (R01DK126728)
Zitieren
APA
LADD, J. M., EATON, A., BEILMAN, G., RICKELS, M. R., & BELLIN, M. (2026). 1142-OR: Counterregulatory Hormone Responses to Hypoglycemia after Total Pancreatectomy with Islet Autotransplantation (TPIAT). Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-1142-or
Vancouver
LADD JM, EATON A, BEILMAN G, RICKELS MR, BELLIN M. 1142-OR: Counterregulatory Hormone Responses to Hypoglycemia after Total Pancreatectomy with Islet Autotransplantation (TPIAT). Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-1142-or
BibTeX
@article{LADD2026,
author = {LADD, JENNIFER M. and EATON, ANNE and BEILMAN, GREG and RICKELS, MICHAEL R. and BELLIN, MELENA},
title = {1142-OR: Counterregulatory Hormone Responses to Hypoglycemia after Total Pancreatectomy with Islet Autotransplantation (TPIAT)},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {Supplement_1},
doi = {10.2337/db26-1142-or}
}
EUVIMED